Provided are methods and apparatus for receiving sensor data from an analyte sensor of a sensor monitoring system, processing the received sensor data with time corresponding calibration data, outputting the processed sensor data, detecting one or more adverse conditions associated with the sensor monitoring system, disabling the output of the sensor data during the adverse condition time period, determining that the one or more detected adverse conditions is no longer present in the sensor monitoring system, retrieving the sensor data during the adverse condition time period, processing the retrieved sensor data during the adverse condition time period, and outputting the processed retrieved sensor data.
|
7. A method, comprising:
detecting a condition unsuitable for calibration of an analyte sensor for a predetermined time period;
disabling output of information associated with the analyte sensor;
storing sensor data received from the analyte sensor during a time period of disabled output of information;
determining a successful calibration of the analyte sensor;
retrieving one or more parameters associated with the successful calibration;
after the one or more parameters associated with successful calibration has been retrieved, processing the sensor data stored during the time period of disabled output of information with the one or more parameters associated with the successful calibration; and
displaying the processed sensor data for the time period of disabled output of information.
1. A method, comprising:
receiving sensor data from an analyte sensor of a sensor monitoring system;
processing the received sensor data with time corresponding calibration data;
outputting the processed sensor data;
detecting one or more adverse conditions associated with the sensor monitoring system;
disabling the output of the sensor data during an adverse condition time period;
storing sensor data received from the analyte sensor during the adverse condition time period;
determining that the one or more detected adverse conditions is no longer present in the sensor monitoring system;
retrieving the sensor data stored during the adverse condition time period after it is determined that the one or more detected adverse conditions is no longer present;
processing the retrieved sensor data stored during the adverse condition time period; and
outputting the processed retrieved sensor data.
14. An apparatus, comprising:
an interface configured to receive sensor data;
a first memory configured to store the received sensor data;
a processor coupled to the first memory and configured to process the stored sensor data;
a second memory coupled to the processor and configured to store the processed sensor data; and
a display unit coupled to the second memory and configured to display the processed sensor data;
wherein the processor is further configured to:
detect a condition unsuitable for calibration of a sensor for a predetermined time period;
disable a display of processed sensor data;
store sensor data received during a time period of disabled display in the first memory;
determine a successful calibration of the sensor;
retrieve one or more parameters associated with the successful calibration;
after the one or more parameters associated with successful calibration have been retrieved, process the sensor data stored during the time period of disabled display of sensor data with the one or more parameters associated with the successful calibration; and
display the processed sensor data for the time period of disabled display.
2. The method of
3. The method of
4. The method of
5. The method of
6. The method of
9. The method of
11. The method of
12. The method of
13. The method of
18. The apparatus of
19. The apparatus of
20. The apparatus of
21. The apparatus of
22. The apparatus of
|
The present application claims priority under 35 U.S.C. §119(e) to U.S. provisional application No. 61/173,600 filed Apr. 29, 2009, entitled “Method and System for Providing Real Time Analyte Sensor Calibration with Retrospective Backfill”, the disclosure of which is incorporated in its entirety by reference for all purposes.
Analyte, e.g., glucose monitoring systems including continuous and discrete monitoring systems generally include a small, lightweight battery powered and microprocessor controlled system which is configured to detect signals proportional to the corresponding measured glucose levels using an electrometer. RF signals may be used to transmit the collected data. One aspect of certain analyte monitoring systems include a transcutaneous or subcutaneous analyte sensor configuration which is, for example, at least partially positioned through the skin layer of a subject whose analyte level is to be monitored. The sensor may use a two or three-electrode (work, reference and counter electrodes) configuration driven by a controlled potential (potentiostat) analog circuit connected through a contact system.
An analyte sensor may be configured so that a portion thereof is placed under the skin of the patient so as to contact analyte of the patient, and another portion or segment of the analyte sensor may be in communication with the transmitter unit. The transmitter unit may be configured to transmit the analyte levels detected by the sensor over a wireless communication link such as an RF (radio frequency) communication link to a receiver/monitor unit. The receiver/monitor unit may perform data analysis, among other functions, on the received analyte levels to generate information pertaining to the monitored analyte levels.
Devices and methods for analyte monitoring, e.g., glucose monitoring, and/or therapy management system including, for example, medication infusion device are provided. Embodiments include transmitting information from a first location to a second, e.g., using a telemetry system such as RF telemetry. Systems herein include continuous analyte monitoring systems, discrete analyte monitoring systems, and therapy management systems.
Embodiments include receiving sensor data from an analyte sensor of a sensor monitoring system, processing the received sensor data with time corresponding calibration data, outputting the processed sensor data, detecting one or more adverse conditions associated with the sensor monitoring system, disabling the output of the sensor data during an adverse condition time period, determining that the one or more detected adverse conditions is no longer present in the sensor monitoring system, retrieving the sensor data during the adverse condition time period, processing the retrieved sensor data during the adverse condition time period, and outputting the processed retrieved sensor data.
Embodiments include detecting a condition unsuitable for calibration of an analyte sensor for a predetermined time period, disabling output of information associated with the analyte sensor, determining a successful calibration of the analyte sensor, retrieving one or more parameters associated with the successful calibration, processing sensor data during the time period of disabled output of information with the one or more parameters associated with the successful calibration, and displaying the processed sensor data for the time period of disabled information output.
Embodiments include an interface configured to receive sensor data, a first memory configured to store the received sensor data, a processor coupled to the memory and configured to process the stored sensor data, a second memory coupled to the processor and configured to store the processed sensor data, and a display unit coupled to the second memory and configured to display the processed sensor data, where the processor is further configured to detect a condition unsuitable for calibration of a sensor for a predetermined time period, disable display of processed sensor data, determine a successful calibration of the sensor, retrieve one or more parameters associated with the successful calibration, process the sensor data during the time period of disabled display of sensor data with the one or more parameters associated with the successful calibration, and display the processed sensor data for the time period of disabled information output.
These and other objects, features and advantages of the present disclosure will become more fully apparent from the following detailed description of the embodiments, the appended claims and the accompanying drawings.
The following patents, applications and/or publications are incorporated herein by reference for all purposes: U.S. Pat. Nos. 4,545,382; 4,711,245; 5,262,035; 5,262,305; 5,264,104; 5,320,715; 5,509,410; 5,543,326; 5,593,852; 5,601,435; 5,628,890; 5,820,551; 5,822,715; 5,899,855; 5,918,603; 6,071,391; 6,103,033; 6,120,676; 6,121,009; 6,134,461; 6,143,164; 6,144,837; 6,161,095; 6,175,752; 6,270,455; 6,284,478; 6,299,757; 6,338,790; 6,377,894; 6,461,496; 6,503,381; 6,514,460; 6,514,718; 6,540,891; 6,560,471; 6,579,690; 6,591,125; 6,592,745; 6,600,997; 6,605,200; 6,605,201; 6,616,819; 6,618,934; 6,650,471; 6,654,625; 6,676,816; 6,730,200; 6,736,957; 6,746,582; 6,749,740; 6,764,581; 6,773,671; 6,881,551; 6,893,545; 6,932,892; 6,932,894; 6,942,518; 7,167,818; and 7,299,082; U.S. Published Application Nos. 2004/0186365; 2005/0182306; 2007/0056858; 2007/0068807; 2007/0227911; 2007/0233013; 2008/0081977; 2008/0161666; and 2009/0054748; U.S. patent application Ser. Nos. 11/831,866; 11/831,881; 11/831,895; 12/102,839; 12/102,844; 12/102,847; 12/102,855; 12/102,856; 12/152,636; 12/152,648; 12/152,650; 12/152,652; 12/152,657; 12/152,662; 12/152,670; 12/152,673; 12/363,712; 12/131,012; 12/242,823; 12/363,712; 12/393,921; 12/495,709; 12/698,124; 12/699,653; 12/699,844; 12/714,439; 12/761,372; and 12/761,387 and U.S. Provisional Application Ser. Nos. 61/230,686 and 61/227,967.
Before the present disclosure is described in additional detail, it is to be understood that this disclosure is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the disclosure. That the upper and lower limits of these smaller ranges may independently be included in the smaller ranges is also encompassed within the disclosure, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.
It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.
The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.
As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure.
The figures shown herein are not necessarily drawn to scale, with some components and features being exaggerated for clarity.
As described in further detail below, in accordance with the various embodiments of the present disclosure, there is provided a method and system for positioning a controller unit within a transmission range for close proximity communication, transmitting one or more predefined close proximity commands, and receiving a response packet in response to the transmitted one or more predefined close proximity commands. For example, in one aspect, close proximity communication includes short range wireless communication between communication components or devices, where the communication range is limited to about 10 inches or less, about 5 inches or less, or about 2 inches or less, or other suitable, short range or distance between the devices. The close proximity wireless communication in certain embodiments includes a bi-directional communication where a command sending communication device, when positioned within the short communication range or in close proximity to the command receiving communication device, is configured to transmit one or more commands to the command receiving communication device (for example, when a user activates or actuates a transmit command button or switch). In response, the command receiving communication device may be configured to perform one or more routines associated with the received command, and/or return or send back a response data packet or signal to the command sending communication device. Example of such functions and or commands may include, but not limited to activation of certain functions or routines such as analyte related data processing, and the like.
Analytes that may be monitored include, for example, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored. More than one analyte may be monitored by a single system, e.g. a single analyte sensor.
The analyte monitoring system 100 includes a sensor unit 101, a data processing and transmitter unit 102 coupleable to the sensor unit 101, and a primary receiver unit 104 which is configured to communicate with the data processing and transmitter unit 102 via a bi-directional communication link 103. The primary receiver unit 104 may be further configured to transmit data to a data processing terminal 105 for evaluating the data received by the primary receiver unit 104. Moreover, the data processing terminal 105 in one embodiment may be configured to receive data directly from the data processing and transmitter unit 102 via a communication link which may optionally be configured for bi-directional communication. Accordingly, data processing and transmitter unit 102 and/or receiver unit 104 may include a transceiver.
Also shown in
In one aspect sensor unit 101 may include two or more sensors, each configured to communicate with data processing and transmitter unit 102. Furthermore, while only one data processing and transmitter unit 102, communication link 103, and data processing terminal 105 are shown in the embodiment of the analyte monitoring system 100 illustrated in
In one embodiment of the present disclosure, the sensor unit 101 is physically positioned in or on the body of a user whose analyte level is being monitored. The sensor unit 101 may be configured to continuously sample the analyte level of the user and convert the sampled analyte level into a corresponding data signal for transmission by the data processing and transmitter unit 102. In certain embodiments, the data processing and transmitter unit 102 may be physically coupled to the sensor unit 101 so that both devices are integrated in a single housing and positioned on the user's body. The data processing and transmitter unit 102 may perform data processing such as filtering and encoding on data signals and/or other functions, each of which corresponds to a sampled analyte level of the user, and in any event data processing and transmitter unit 102 transmits analyte information to the primary receiver unit 104 via the communication link 103. Examples of such integrated sensor and transmitter units can be found in, among others, U.S. patent application Ser. No. 12/698,124, incorporated herein by reference.
In one embodiment, the analyte monitoring system 100 is configured as a one-way RF communication path from the data processing and transmitter unit 102 to the primary receiver unit 104. In such embodiment, the data processing and transmitter unit 102 transmits the sampled data signals received from the sensor unit 101 without acknowledgement from the primary receiver unit 104 that the transmitted sampled data signals have been received. For example, the data processing and transmitter unit 102 may be configured to transmit the encoded sampled data signals at a fixed rate (e.g., at one minute intervals) after the completion of the initial power on procedure. Likewise, the primary receiver unit 104 may be configured to detect such transmitted encoded sampled data signals at predetermined time intervals. Alternatively, the analyte monitoring system 100 may be configured with a bi-directional RF (or otherwise) communication between the data processing and transmitter unit 102 and the primary receiver unit 104.
Additionally, in one aspect, the primary receiver unit 104 may include two sections. The first section is an analog interface section that is configured to communicate with the data processing and transmitter unit 102 via the communication link 103. In one embodiment, the analog interface section may include an RF receiver and an antenna for receiving and amplifying the data signals from the data processing and transmitter unit 102, which are thereafter, demodulated with a local oscillator and filtered through a band-pass filter. The second section of the primary receiver unit 104 is a data processing section which is configured to process the data signals received from the data processing and transmitter unit 102 such as by performing data decoding, error detection and correction, data clock generation, and data bit recovery.
In operation, upon completing the power-on procedure, the primary receiver unit 104 is configured to detect the presence of the data processing and transmitter unit 102 within its range based on, for example, the strength of the detected data signals received from the data processing and transmitter unit 102 and/or a predetermined transmitter identification information. Upon successful synchronization with the corresponding data processing and transmitter unit 102, the primary receiver unit 104 is configured to begin receiving from the data processing and transmitter unit 102 data signals corresponding to the user's detected analyte level. More specifically, the primary receiver unit 104 in one embodiment is configured to perform synchronized time hopping with the corresponding synchronized data processing and transmitter unit 102 via the communication link 103 to obtain the user's detected analyte level.
Referring again to
Within the scope of the present disclosure, the data processing terminal 105 may include an infusion device such as an insulin infusion pump (external or implantable) or the like, which may be configured to administer insulin to patients, and which may be configured to communicate with the receiver unit 104 for receiving, among others, the measured analyte level. Alternatively, the receiver unit 104 may be configured to integrate or otherwise couple to an infusion device therein so that the receiver unit 104 is configured to administer insulin therapy to patients, for example, for administering and modifying basal profiles, as well as for determining appropriate boluses for administration based on, among others, the detected analyte levels received from the data processing and transmitter unit 102.
Additionally, the data processing and transmitter unit 102, the primary receiver unit 104 and the data processing terminal 105 may each be configured for bi-directional wireless communication such that each of the data processing and transmitter unit 102, the primary receiver unit 104 and the data processing terminal 105 may be configured to communicate (that is, transmit data to and receive data from) with each other via the wireless communication link 103. More specifically, the data processing terminal 105 may in one embodiment be configured to receive data directly from the data processing and transmitter unit 102 via a communication link, where the communication link, as described above, may be configured for bi-directional communication.
In this embodiment, the data processing terminal 105 which may include an insulin pump, may be configured to receive the analyte signals from the data processing and transmitter unit 102, and thus, incorporate the functions of the receiver 104 including data processing for managing the patient's insulin therapy and analyte monitoring. In one embodiment, the communication link 103 may include one or more of an RF communication protocol, an infrared communication protocol, a Bluetooth® enabled communication protocol, an 802.11x wireless communication protocol, or an equivalent wireless communication protocol which would allow secure, wireless communication of several units (for example, per HIPAA requirements) while avoiding potential data collision and interference.
Further shown in
In one embodiment, a unidirectional input path is established from the sensor unit 101 (
As discussed above, the transmitter processor 204 is configured to transmit control signals to the various sections of the data processing and transmitter unit 102 during the operation of the data processing and transmitter unit 102. In one embodiment, the transmitter processor 204 also includes a memory (not shown) for storing data such as the identification information for the data processing and transmitter unit 102, as well as the data signals received from the sensor unit 101. The stored information may be retrieved and processed for transmission to the primary receiver unit 104 under the control of the transmitter processor 204. Furthermore, the power supply 207 may include a commercially available battery, which may be a rechargeable battery.
In certain embodiments, the data processing and transmitter unit 102 is also configured such that the power supply section 207 is capable of providing power to the transmitter for a minimum of about three months of continuous operation, e.g., after having been stored for about eighteen months such as stored in a low-power (non-operating) mode. In one embodiment, this may be achieved by the transmitter processor 204 operating in low power modes in the non-operating state, for example, drawing no more than approximately 1 μA of current. Indeed, in one embodiment, a step during the manufacturing process of the data processing and transmitter unit 102 may place the data processing and transmitter unit 102 in the lower power, non-operating state (i.e., post-manufacture sleep mode). In this manner, the shelf life of the data processing and transmitter unit 102 may be significantly improved. Moreover, as shown in
Referring back to
Referring yet again to
Referring yet again to
In one embodiment, the test strip interface 301 includes a glucose level testing portion to receive a manual insertion of a glucose test strip, and thereby determine and display the glucose level of the test strip on the output 310 of the primary receiver unit 104. This manual testing of glucose may be used to calibrate the sensor unit 101 or otherwise. The RF receiver 302 is configured to communicate, via the communication link 103 (
Each of the various components of the primary receiver unit 104 shown in
The serial communication section 309 in the primary receiver unit 104 is configured to provide a bi-directional communication path from the testing and/or manufacturing equipment for, among others, initialization, testing, and configuration of the primary receiver unit 104. Serial communication section 309 can also be used to upload data to a computer, such as time-stamped blood glucose data. The communication link with an external device (not shown) can be made, for example, by cable, infrared (IR) or RF link. The output 310 of the primary receiver unit 104 is configured to provide, among others, a graphical user interface (GUI) such as a liquid crystal display (LCD) for displaying information. Additionally, the output 310 may also include an integrated speaker for outputting audible signals as well as to provide vibration output as commonly found in handheld electronic devices, such as mobile telephones presently available. In a further embodiment, the primary receiver unit 104 also includes an electro-luminescent lamp configured to provide backlighting to the output 310 for output visual display in dark ambient surroundings.
Referring back to
Periodic calibration of the sensor unit 101 (
There are time periods where the sensor characteristics or the user's physiological condition renders the condition unsuitable for a sensor calibration event. For example, the sensor may be configured for periodic calibration, such as, after 2 hours after insertion, 10 hours after insertion, 12 hours after insertion, 24 hours after insertion, 48 hours after insertion, or 72 hours after insertion, or one or more combinations thereof. If a predetermined calibration event is triggered but a successful calibration does not result, after a certain time period (for example, a predetermined grace period during which to calibrate), the receiver unit may no longer display the monitored and processed glucose information.
Other conditions may also result in rendering the condition unsuitable for sensor calibration including, but not limited to, detection of a failure mode of a sensor, sensor data values being outside a predetermined range, rate of change of sensor data values being above a predetermined threshold, a temperature measurement outside a predetermined range, or any combination thereof.
Referring still to
Still referring to
In one aspect, the display or output of processed sensor data may be disabled if a required calibration event is unsuccessful over a permitted time period (for example, including a predetermined grace period measured from the scheduled calibration). Thereafter, upon successful calibration, the system resumes display of the processed and calibrated analyte sensor data. However, there may be a time period or a gap in the output display during which the necessary calibration did not occur in a timely manner. For example, as shown in
In one aspect, once successful calibration of the sensor data occurs, the calibration parameters from this calibration event may be used to process the sensor data during the period of disabled output or display (620). Upon successful processing of the sensor data during the period of disabled output, the processed sensor data during this time period is backfilled, or the gap in the processed continuous sensor data are filled in the display (630). By way of an example,
In one embodiment, the backfilled processed sensor data is displayed immediately upon calculation. In another embodiment, the backfilled processed sensor data is not displayed immediately, but rather, after waiting a predetermined period of time. The backfilled processed sensor data may not be displayed immediately to avoid possible unnecessary or incorrect action by a user in response to the backfilled processed sensor data. In this manner, in one aspect, the user or a healthcare provider may be provided with a continuous set of analyte data from the analyte monitoring system without any gaps in the processed signals for further analysis and/or therapy management.
In this manner, in accordance with the embodiments of the present disclosure, gaps in monitored analyte levels using an analyte monitoring system due to, for example, inability to promptly calibrate the sensor, system malfunction, sensor dislodging, signal errors associated with the sensor, transmitter unit, receiver unit, and the like, or any other variables or parameters that result in the inability of the analyte monitoring system to display or output the real-time monitored analyte level, may be retrospectively filled or reprocessed so that the data gap is closed and the continuously monitored analyte level does not have any or substantially missing data. That is, in embodiments of the present disclosure, upon correction or rectification of the condition or conditions/parameters which resulted in the analyte monitoring system disabling the output results associated with the monitored real time analyte levels, the parameters associated with the correction or rectification may be used to retrospectively correct or process data or signals so that the missing gaps in analyte related data may be processed and backfilled.
In this manner, advantageously, in aspects of the present disclosure, additional robustness may be provided to the user and/or the healthcare provider to improve therapy or health management decisions.
In one embodiment, a method may include receiving sensor data from an analyte sensor of a sensor monitoring system, processing the received sensor data with time corresponding calibration data, outputting the processed sensor data, detecting one or more adverse conditions associated with the sensor monitoring system, disabling the output of the sensor data during an adverse condition time period, determining that the one or more detected adverse conditions is no longer present in the sensor monitoring system, retrieving the sensor data during the adverse condition time period, processing the retrieved sensor data during the adverse condition time period, and outputting the processed retrieved sensor data.
In one aspect, outputting the processed sensor data may include displaying the sensor data in one or more of a graphical, numerical, pictorial, audible, vibratory, or one or more combinations thereof.
The one or more detected adverse conditions may include one or more of a sensor instability condition, a calibration failure condition, or a monitoring system failure condition.
The sensor instability condition may include one or more of an early signal attenuation condition of the sensor, sensor misposition error, sensor communication error, temperature measurement outside a predetermined range, or a combination thereof.
The calibration failure condition may include one or more of an analyte level exceeding a predetermined threshold, a rate of change of analyte level exceeding a predetermined threshold, a signal error associated with the reference data, a data unavailability condition, or a combination thereof.
Furthermore, the method may include storing the processed sensor data with the associated time information based on the analyte level detection time by the sensor.
In another embodiment, a method may include detecting a condition unsuitable for calibration of an analyte sensor for a predetermined time period, disabling output of information associated with the analyte sensor, determining a successful calibration of the analyte sensor, retrieving one or more parameters associated with the successful calibration, processing sensor data during the time period of disabled output of information with the one or more parameters associated with the successful calibration, and displaying the processed sensor data for the time period of disabled information output.
The sensor data may be analyte concentration data.
The analyte concentration data may include blood glucose concentration data.
The sensor data may be processed in substantially real-time.
The condition unsuitable for calibration may include one or more of a failure mode of a sensor, sensor data outside a predetermined acceptable range, a rate of change of sensor data above a predetermined level, a requirement for calibration of a sensor, a temperature measurement outside a predetermined range, or any combination thereof.
The processed sensor data for the time period of disabled information output may be displayed immediately upon processing.
The processed sensor data for the time period of disabled information output may be displayed only after waiting a predetermined period of time.
In another embodiment, an apparatus may include an interface configured to receive sensor data, a first memory configured to store the received sensor data, a processor coupled to the memory and configured to process the stored sensor data, a second memory coupled to the processor and configured to store the processed sensor data, and a display unit coupled to the second memory and configured to display the processed sensor data, wherein the processor is further configured to detect a condition unsuitable for calibration of a sensor for a predetermined time period, disable display of processed sensor data, determine a successful calibration of the sensor, retrieve one or more parameters associated with the successful calibration, process the sensor data during the time period of disabled display of sensor data with the one or more parameters associated with the successful calibration, and display the processed sensor data for the time period of disabled information output.
The sensor may be an analyte sensor.
The analyte sensor may be a glucose sensor.
The sensor data may correspond to analyte concentration data.
The analyte concentration data may include blood glucose concentration data.
Furthermore, the apparatus may be configured to process and display the sensor data substantially in real-time.
In one aspect, the condition unsuitable for calibration may include one or more of a failure mode of a sensor, sensor data outside a predetermined acceptable range, a rate of change of sensor data above a predetermined level, a requirement for calibration of a sensor, a temperature measurement outside a predetermined range, or any combination thereof.
The display unit may be configured to display the processed sensor data for the time period of disabled information output substantially immediately upon processing the sensor data.
The display unit may be configured to display the processed sensor data for the time period of disabled information output only after waiting a predetermined period of time.
Various other modifications and alterations in the structure and method of operation of this invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby.
Patent | Priority | Assignee | Title |
10085640, | May 12 2015 | DEXCOM, INC | Distributed system architecture for continuous glucose monitoring |
10226205, | Nov 07 2013 | DexCom, Inc. | Systems and methods for a continuous monitoring of analyte values |
10376144, | May 12 2015 | DEXCOM, INC | Distributed system architecture for continuous glucose monitoring |
10813592, | Jun 13 2014 | Medtronic MiniMed, Inc. | Physiological sensor history backfill system and method |
10863931, | Nov 07 2013 | DexCom, Inc. | Systems and methods for a continuous monitoring of analyte values |
11399742, | Nov 07 2013 | DexCom, Inc. | Systems and methods for a continuous monitoring of analyte values |
11484232, | Jan 23 2018 | DEXCOM, INC | Systems, devices, and methods to compensate for temperature effects on sensors |
11484233, | Jan 23 2018 | DEXCOM, INC | Systems, devices, and methods to compensate for temperature effects on sensors |
11559230, | Jan 23 2018 | DEXCOM, INC | Systems, devices, and methods to compensate for temperature effects on sensors |
11730402, | Nov 07 2013 | DexCom, Inc. | Systems and methods for a continuous monitoring of analyte values |
11756682, | May 12 2015 | DexCom, Inc. | Distributed system architecture for continuous glucose monitoring |
9901292, | Nov 07 2013 | DexCom, Inc. | Systems and methods for a continuous monitoring of analyte values |
9901305, | Jun 13 2014 | Medtronic MiniMed, Inc. | Physiological sensor history backfill system and method |
9974018, | Sep 23 2011 | DEXCOM, INC | Systems and methods for processing and transmitting sensor data |
9974470, | Nov 07 2013 | DexCom, Inc. | Systems and methods for a continuous monitoring of analyte values |
9980223, | Sep 23 2011 | DexCom, Inc. | Systems and methods for processing and transmitting sensor data |
9999379, | Nov 07 2013 | DexCom, Inc. | Systems and methods for a continuous monitoring of analyte values |
Patent | Priority | Assignee | Title |
3581062, | |||
3926760, | |||
3949388, | Nov 17 1971 | Monitron Industries, Inc. | Physiological sensor and transmitter |
4036749, | Apr 30 1975 | Purification of saline water | |
4055175, | May 07 1976 | Miles Laboratories, Inc. | Blood glucose control apparatus |
4129128, | Feb 23 1977 | TAUT, INC , 2571 KANEVILLE ROAD, GENEVA, COUNTY KANE, ILLINOIS, A DE CORP | Securing device for catheter placement assembly |
4245634, | Dec 11 1975 | Hospital For Sick Children | Artificial beta cell |
4327725, | Nov 25 1980 | ALZA Corporation | Osmotic device with hydrogel driving member |
4344438, | Aug 02 1978 | The United States of America as represented by the Department of Health, | Optical sensor of plasma constituents |
4349728, | Dec 07 1978 | LOMAH ELECTRONIC TARGETRY, INC , 333 KEY PALM ROAD, BOCA RATON, FL A CORP OF FL | Target apparatus |
4373527, | Apr 27 1979 | The Johns Hopkins University | Implantable, programmable medication infusion system |
4392849, | Jul 27 1981 | The Cleveland Clinic Foundation | Infusion pump controller |
4425920, | Oct 24 1980 | Purdue Research Foundation | Apparatus and method for measurement and control of blood pressure |
4478976, | Sep 25 1981 | BASF Aktiengesellschaft | Water-insoluble protein material, its preparation and its use |
4494950, | Jan 19 1982 | The Johns Hopkins University | Plural module medication delivery system |
4509531, | Jul 28 1982 | AVIONICS SPECIALTIES, INC | Personal physiological monitor |
4527240, | Dec 29 1982 | RELONIX, INC | Balascopy method for detecting and rapidly evaluating multiple imbalances within multi-parametric systems |
4538616, | Jul 25 1983 | Blood sugar level sensing and monitoring transducer | |
4619793, | Apr 29 1982 | Ciba-Geigy Corporation | Method of producing annealed polyvinyl alcohol contact lens |
4671288, | Jun 13 1985 | The Regents of the University of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
4703756, | May 06 1986 | Regents of the University of California, The | Complete glucose monitoring system with an implantable, telemetered sensor module |
4731726, | May 19 1986 | Roche Diabetes Care, Inc | Patient-operated glucose monitor and diabetes management system |
4749985, | Apr 13 1987 | United States of America as represented by the United States Department | Functional relationship-based alarm processing |
4757022, | Sep 10 1985 | DEXCOM, INC | Biological fluid measuring device |
4777953, | Feb 25 1987 | ASH ACCESS TECHNOLOGY, INC | Capillary filtration and collection method for long-term monitoring of blood constituents |
4779618, | Aug 10 1984 | Pacesetter AB | Device and method for the physiological frequency control of a heart pacemaker equipped with a stimulating electrode |
4854322, | Feb 25 1987 | ASH ACCESS TECHNOLOGY, INC | Capillary filtration and collection device for long-term monitoring of blood constituents |
4871351, | Sep 28 1984 | Implantable medication infusion system | |
4890620, | Sep 20 1985 | The Regents of the University of California | Two-dimensional diffusion glucose substrate sensing electrode |
4925268, | Jul 25 1988 | HOSPIRA, INC | Fiber-optic physiological probes |
4953552, | Apr 21 1989 | Blood glucose monitoring system | |
4986271, | Jul 19 1989 | University of New Mexico | Vivo refillable glucose sensor |
4995402, | Oct 12 1988 | Thorne, Smith, Astill Technologies, Inc.; THORNE, SMITH, ASTILL TECHNOLOGIES, INC , 1056 MILLCREST CIRCLE, BOUNTIFUL, UT 84010, A CORP OF DE | Medical droplet whole blood and like monitoring |
5000180, | Aug 03 1988 | DRAGER NEDERLAND B V | Polarographic-amperometric three-electrode sensor |
5002054, | Feb 25 1987 | Volcano Corporation | Interstitial filtration and collection device and method for long-term monitoring of physiological constituents of the body |
5019974, | May 01 1987 | EURUS LLC; DIVA MEDICAL MANAGEMENT SYSTEMS BY | Diabetes management system and apparatus |
5050612, | Sep 12 1989 | Device for computer-assisted monitoring of the body | |
5055171, | Oct 06 1986 | T AND G CORPORATION A CT CORPORATION | Ionic semiconductor materials and applications thereof |
5068536, | Jan 19 1989 | Futrex, Inc. | Method for providing custom calibration for near infrared instruments for measurement of blood glucose |
5082550, | Dec 11 1989 | The United States of America as represented by the Department of Energy | Enzyme electrochemical sensor electrode and method of making it |
5106365, | Jun 16 1989 | Europhor SA | Microdialysis probe |
5122925, | Apr 22 1991 | Control Products, Inc. | Package for electronic components |
5165407, | Apr 19 1990 | UNIVERSITY OF KANSAS, THE, | Implantable glucose sensor |
5231988, | Aug 09 1991 | LivaNova USA, Inc | Treatment of endocrine disorders by nerve stimulation |
5246867, | Jan 17 1992 | LAKOWICZ, JOSEPH R , PH D | Determination and quantification of saccharides by luminescence lifetimes and energy transfer |
5262035, | Aug 02 1989 | Abbott Diabetes Care Inc | Enzyme electrodes |
5262305, | Mar 04 1991 | THERASENSE, INC | Interferant eliminating biosensors |
5264104, | Aug 02 1989 | THERASENSE, INC | Enzyme electrodes |
5264105, | May 08 1992 | THERASENSE, INC | Enzyme electrodes |
5279294, | Jul 25 1986 | KUDD, ARTHUR R ; DAYTON, JUDSON M | Medical diagnostic system |
5285792, | Jan 10 1992 | CREDITANSTALT BANKVEREIN | System for producing prioritized alarm messages in a medical instrument |
5293877, | Dec 11 1991 | Covidien AG | Body temperature thermometer and method fo measuring human body temperature utilizing calibration mapping |
5299571, | Jan 22 1993 | Disetronic Licensing AG | Apparatus and method for implantation of sensors |
5320725, | Aug 02 1989 | THERASENSE, INC | Electrode and method for the detection of hydrogen peroxide |
5322063, | Oct 04 1991 | Disetronic Licensing AG | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
5340722, | Aug 24 1988 | AVL Medical Instruments AG | Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method |
5342789, | Dec 14 1989 | SENSOR TECHNOLOGIES, INC | Method and device for detecting and quantifying glucose in body fluids |
5356786, | Mar 04 1991 | THERASENSE, INC | Interferant eliminating biosensor |
5360404, | Dec 14 1988 | INVIRO MEDICAL DEVICES, INC | Needle guard and needle assembly for syringe |
5372427, | Dec 19 1991 | TEXAS INSTRUMENTS INCORPORATED A CORPORATION OF DE | Temperature sensor |
5379238, | Mar 03 1989 | Signal processing method and apparatus | |
5384547, | Aug 02 1993 | Motorola Mobility LLC | Apparatus and method for attenuating a multicarrier input signal of a linear device |
5390671, | Mar 15 1994 | MEDTRONIC MINIMED, INC | Transcutaneous sensor insertion set |
5391250, | Mar 15 1994 | MEDTRONIC MINIMED, INC | Method of fabricating thin film sensors |
5408999, | Oct 23 1992 | BRUCE A MCKINLEY | Fiber-optic probe for the measurement of fluid parameters |
5411647, | Nov 23 1992 | Disetronic Licensing AG | Techniques to improve the performance of electrochemical sensors |
5425868, | Jul 24 1992 | RADIOMETER MEDICAL APS | Sensor for non-invasive, in vivo determination of an analyte and blood flow |
5431160, | Jul 19 1989 | University of New Mexico | Miniature implantable refillable glucose sensor and material therefor |
5431921, | Sep 28 1990 | Pfizer Inc | Dispensing device containing a hydrophobic medium |
5462645, | Sep 20 1991 | Imperial College of Science, Technology & Medicine | Dialysis electrode device |
5497772, | Nov 19 1993 | MANN, ALFRED E , FOUNDATION FOR SCIENTIFIC RESEARCH | Glucose monitoring system |
5507288, | May 05 1994 | Boehringer Mannheim GmbH | Analytical system for monitoring a substance to be analyzed in patient-blood |
5509410, | Jun 06 1983 | MediSense, Inc. | Strip electrode including screen printing of a single layer |
5514718, | Mar 03 1992 | ZIMMER, INC | Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
5531878, | May 13 1993 | The Victoria University of Manchester | Sensor devices |
5568806, | Feb 16 1995 | MEDTRONIC MINIMED, INC | Transcutaneous sensor insertion set |
5569186, | Apr 25 1994 | MEDTRONIC MINIMED, INC | Closed loop infusion pump system with removable glucose sensor |
5582184, | Oct 13 1993 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
5586553, | Feb 16 1995 | MEDTRONIC MINIMED, INC | Transcutaneous sensor insertion set |
5593852, | Dec 02 1993 | Abbott Diabetes Care Inc | Subcutaneous glucose electrode |
5609575, | Apr 11 1994 | Graseby Medical Limited | Infusion pump and method with dose-rate calculation |
5628310, | May 19 1995 | LAKOWICZ, JOSEPH R | Method and apparatus to perform trans-cutaneous analyte monitoring |
5653239, | Mar 08 1991 | PNC Bank, National Association | Continuous temperature monitor |
5665222, | Oct 11 1995 | THERASENSE, INC | Soybean peroxidase electrochemical sensor |
5711001, | May 08 1992 | Motorola Mobility, Inc | Method and circuit for acquisition by a radio receiver |
5711861, | Nov 22 1995 | Legacy Good Samaritan Hospital and Medical Center | Device for monitoring changes in analyte concentration |
5733259, | Jan 31 1992 | Gensia Pharmaceuticals, Inc. | Method and apparatus for closed loop drug delivery |
5772586, | Feb 12 1996 | Nokia Technologies Oy | Method for monitoring the health of a patient |
5791344, | Nov 19 1993 | ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH | Patient monitoring system |
5899855, | Nov 17 1992 | HEALTH HERO NETWORK, INC | Modular microprocessor-based health monitoring system |
5925021, | Mar 09 1994 | Becton, Dickinson and Company | Medication delivery device with a microprocessor and characteristic monitor |
5935224, | Apr 24 1997 | Microsoft Technology Licensing, LLC | Method and apparatus for adaptively coupling an external peripheral device to either a universal serial bus port on a computer or hub or a game port on a computer |
5942979, | Apr 07 1997 | On guard vehicle safety warning system | |
5957854, | Sep 04 1993 | Body Science LLC | Wireless medical diagnosis and monitoring equipment |
5964993, | Dec 19 1996 | TENAX THERAPEUTICS, INC | Glucose sensor |
5965380, | Dec 02 1993 | THERASENSE, INC | Subcutaneous glucose electrode |
5971922, | Apr 07 1998 | RESEARCH INSTITUTE OF APPLICATION TECHNOLOGIES FOR CHAOS & COMPLEX SYSTEMS CO , LTD | System and method for predicting blood glucose level |
5995860, | Jul 06 1995 | Thomas Jefferson University | Implantable sensor and system for measurement and control of blood constituent levels |
6001067, | Mar 04 1997 | DEXCOM, INC | Device and method for determining analyte levels |
6024699, | Mar 13 1998 | HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR ADMINISTRATIVE AGENT | Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients |
6049727, | Apr 03 1998 | Animas Corporation | Implantable sensor and system for in vivo measurement and control of fluid constituent levels |
6083710, | Dec 02 1993 | THERASENSE, INC | Electrochemical analyte measurement system |
6088608, | Oct 20 1997 | ALFRED E MANN FOUNDATION | Electrochemical sensor and integrity tests therefor |
6091976, | May 09 1996 | Roche Diagnostics GmbH | Determination of glucose concentration in tissue |
6093172, | Feb 05 1997 | MEDTRONIC MINIMED, INC | Injector for a subcutaneous insertion set |
6103033, | Mar 04 1998 | THERASENSE, INC | Process for producing an electrochemical biosensor |
6117290, | Sep 26 1997 | Pepex Biomedical, LLC | System and method for measuring a bioanalyte such as lactate |
6119028, | Oct 20 1997 | ALFRED E MANN FOUNDATION | Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
6120676, | Feb 06 1997 | THERASENSE, INC | Method of using a small volume in vitro analyte sensor |
6121009, | Dec 02 1993 | THERASENSE, INC | Electrochemical analyte measurement system |
6121611, | May 20 1998 | Keysight Technologies, Inc | Force sensing probe for scanning probe microscopy |
6122351, | Jan 21 1997 | MED GRAPH, INC | Method and system aiding medical diagnosis and treatment |
6134461, | Mar 04 1998 | Abbott Diabetes Care Inc | Electrochemical analyte |
6162611, | Dec 02 1993 | THERASENSE, INC | Subcutaneous glucose electrode |
6175752, | Apr 30 1998 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
6200265, | Apr 16 1999 | Medtronic, Inc.; Medtronic, Inc | Peripheral memory patch and access method for use with an implantable medical device |
6212416, | Nov 22 1995 | Legacy Good Samaritan Hospital and Medical Center | Device for monitoring changes in analyte concentration |
6219574, | Jun 17 1997 | ALZA Corporation | Device and method for enchancing transdermal sampling |
6233471, | May 13 1998 | Lifescan IP Holdings, LLC | Signal processing for measurement of physiological analysis |
6248067, | Feb 05 1999 | MEDTRONIC MINIMED, INC | Analyte sensor and holter-type monitor system and method of using the same |
6275717, | Jun 16 1997 | Alkermes Pharma Ireland Limited | Device and method of calibrating and testing a sensor for in vivo measurement of an analyte |
6284478, | Dec 02 1993 | Abbott Diabetes Care Inc | Subcutaneous glucose electrode |
6293925, | Dec 31 1997 | MEDTRONIC MINIMED, INC | Insertion device for an insertion set and method of using the same |
6295506, | Oct 27 1997 | RPX Corporation | Measurement apparatus |
6306104, | Dec 06 1996 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
6309884, | Feb 26 1997 | Dominion Assets, LLC | Individual calibration of blood glucose for supporting noninvasive self-monitoring blood glucose |
6329161, | Dec 02 1993 | Abbott Diabetes Care Inc | Subcutaneous glucose electrode |
6360888, | Feb 25 1999 | MEDTRONIC MINIMED, INC | Glucose sensor package system |
6366794, | Nov 20 1998 | University of Connecticut, The; PRECISION CONTROL DESIGN, INC | Generic integrated implantable potentiostat telemetry unit for electrochemical sensors |
6377828, | Nov 12 1997 | LighTouch Medical, Inc. | Method for non-invasive measurement of an analyte |
6379301, | Jan 10 1997 | Health Hero Network | Diabetes management system and method for controlling blood glucose |
6424847, | Feb 25 1999 | MEDTRONIC MINIMED, INC | Glucose monitor calibration methods |
6427088, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method using telemetry system with predefined reception listening periods |
6440068, | Apr 28 2000 | International Business Machines Corporation | Measuring user health as measured by multiple diverse health measurement devices utilizing a personal storage device |
6478736, | Oct 08 1999 | MICROLIFE MEDICAL HOME SOLUTIONS INC | Integrated calorie management system |
6484046, | Mar 04 1998 | Abbott Diabetes Care Inc | Electrochemical analyte sensor |
6514718, | Mar 04 1991 | TheraSense, Inc. | Subcutaneous glucose electrode |
6544212, | Jul 31 2001 | Roche Diabetes Care, Inc | Diabetes management system |
6551494, | Feb 06 1997 | Abbott Diabetes Care Inc | Small volume in vitro analyte sensor |
6558321, | Mar 04 1997 | DEXCOM INC | Systems and methods for remote monitoring and modulation of medical devices |
6558351, | Jun 03 1999 | MEDTRONIC MINIMED, INC | Closed loop system for controlling insulin infusion |
6560471, | Jan 02 2001 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
6561978, | Feb 12 1999 | Lifescan IP Holdings, LLC | Devices and methods for frequent measurement of an analyte present in a biological system |
6562001, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
6564105, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data |
6565509, | Apr 30 1998 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
6571128, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
6576101, | Feb 06 1997 | THERASENSE, INC | Small volume in vitro analyte sensor |
6577899, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
6579690, | Dec 05 1997 | Abbott Diabetes Care Inc | Blood analyte monitoring through subcutaneous measurement |
6585644, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
6591125, | Jun 27 2000 | Abbott Diabetes Care Inc | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
6595919, | May 13 1998 | Lifescan IP Holdings, LLC | Device for signal processing for measurement of physiological analytes |
6605200, | Nov 15 1999 | Abbott Diabetes Care Inc | Polymeric transition metal complexes and uses thereof |
6605201, | Nov 15 1999 | Abbott Diabetes Care Inc | Transition metal complexes with bidentate ligand having an imidazole ring and sensor constructed therewith |
6607509, | Dec 31 1997 | MEDTRONIC MINIMED, INC | Insertion device for an insertion set and method of using the same |
6610012, | Apr 10 2000 | MICROLIFE MEDICAL HOME SOLUTIONS INC | System and method for remote pregnancy monitoring |
6633772, | Aug 18 2000 | Lifescan IP Holdings, LLC | Formulation and manipulation of databases of analyte and associated values |
6635014, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method having telemetry modifiable control software |
6648821, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
6654625, | Jun 18 1999 | Abbott Diabetes Care Inc | Mass transport limited in vivo analyte sensor |
6659948, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
6668196, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus with hand held communication device |
6687546, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method using a robust communication protocol |
6689056, | Apr 07 1999 | Given Imaging LTD | Implantable monitoring probe |
6694191, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method having telemetry modifiable control software |
6695860, | Nov 13 2000 | KONAMITE LIMITED | Transcutaneous sensor insertion device |
6698269, | Apr 27 2001 | Oceana Sensor Technologies, Inc. | Transducer in-situ testing apparatus and method |
6702857, | Jul 27 2001 | DEXCOM, INC | Membrane for use with implantable devices |
6733446, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
6740075, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus with hand held communication device |
6741877, | Mar 04 1997 | DEXCOM, INC | Device and method for determining analyte levels |
6746582, | May 12 2000 | Abbott Diabetes Care Inc | Electrodes with multilayer membranes and methods of making the electrodes |
6758810, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method using a robust communication protocol |
6770030, | Sep 17 1999 | Device for conducting in vivo measurements of quantities in living organisms | |
6790178, | Sep 24 1999 | MICROLIFE MEDICAL HOME SOLUTIONS INC | Physiological monitor and associated computation, display and communication unit |
6809653, | Oct 08 1998 | MEDTRONIC MINIMED, INC | Telemetered characteristic monitor system and method of using the same |
6810290, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus with hand held communication device |
6811533, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method using a robust communication protocol |
6811534, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
6813519, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus and method using a robust communication protocol |
6862465, | Mar 04 1997 | DEXCOM, INC | Device and method for determining analyte levels |
6873268, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
6881551, | Mar 04 1991 | TheraSense, Inc. | Subcutaneous glucose electrode |
6885883, | May 16 2000 | Lifescan IP Holdings, LLC | Methods for improving performance and reliability of biosensors |
6892085, | Feb 25 1999 | Medtronic MiniMed, Inc. | Glucose sensor package system |
6895263, | Feb 23 2000 | Medtronic MiniMed, Inc. | Real time self-adjusting calibration algorithm |
6895265, | May 15 2000 | Implantable sensor | |
6931327, | Aug 01 2003 | DEXCOM, INC | System and methods for processing analyte sensor data |
6932894, | May 15 2001 | Abbott Diabetes Care Inc | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
6936006, | Mar 22 2002 | Novo Nordisk A S | Atraumatic insertion of a subcutaneous device |
6950708, | Jan 21 2000 | Medtronic MiniMed, Inc. | Ambulatory medical apparatus and method using a telemetry system with predefined reception listening |
6958705, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
6968294, | Mar 15 2001 | Koninklijke Philips Electronics N.V. | Automatic system for monitoring person requiring care and his/her caretaker |
6971274, | Apr 02 2004 | SIERRA INSTRUMENTS, INC | Immersible thermal mass flow meter |
6974437, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
6990366, | Apr 30 1998 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
6997907, | Feb 05 1997 | Medtronic MiniMed, Inc. | Insertion device for an insertion set and method of using the same |
6998247, | Mar 08 2002 | GLT ACQUISITION CORP | Method and apparatus using alternative site glucose determinations to calibrate and maintain noninvasive and implantable analyzers |
7003336, | Feb 10 2000 | MEDTRONIC MINIMED, INC | Analyte sensor method of making the same |
7003340, | Mar 04 1998 | Abbott Diabetes Care Inc | Electrochemical analyte sensor |
7003341, | Apr 30 1998 | Abbott Diabetes Care, Inc. | Analyte monitoring devices and methods of use |
7022072, | Dec 27 2001 | MEDTRONICS MINIMED, INC | System for monitoring physiological characteristics |
7024245, | Jan 21 2000 | Medtronic MiniMed, Inc. | Ambulatory medical apparatus and method using a robust communication protocol |
7029444, | Feb 23 2000 | Medtronic MiniMed, Inc. | Real time self-adjusting calibration algorithm |
7041068, | Jun 12 2001 | Sanofi-Aventis Deutschland GmbH | Sampling module device and method |
7043287, | May 18 1998 | Abbott Diabetes Care Inc | Method for modulating light penetration depth in tissue and diagnostic applications using same |
7052483, | Dec 19 2000 | Lifescan IP Holdings, LLC | Transcutaneous inserter for low-profile infusion sets |
7056302, | Feb 26 2002 | Ypsomed AG | Insertion device for an insertion set and method of using the same |
7074307, | Jul 25 2003 | DexCom, Inc. | Electrode systems for electrochemical sensors |
7081195, | Dec 08 2003 | DEXCOM, INC | Systems and methods for improving electrochemical analyte sensors |
7098803, | Oct 08 1998 | Medtronic MiniMed, Inc. | Telemetered characteristic monitor system and method of using the same |
7108778, | Jul 25 2003 | DEXCOM, INC | Electrochemical sensors including electrode systems with increased oxygen generation |
7110803, | Mar 04 1997 | DexCom, Inc. | Device and method for determining analyte levels |
7113821, | Aug 25 1999 | Lifescan, Inc | Tissue electroperforation for enhanced drug delivery |
7118667, | Jun 02 2004 | Biosensors having improved sample application and uses thereof | |
7134999, | Apr 04 2003 | DEXCOM, INC | Optimized sensor geometry for an implantable glucose sensor |
7136689, | Mar 04 1997 | DexCom, Inc. | Device and method for determining analyte levels |
7171274, | Jan 21 2000 | Medtronic MiniMed, Inc. | Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data |
7190988, | Apr 30 1998 | SYNTHEON NEUROVASCULAR LLC | Analyte monitoring device and methods of use |
7192450, | May 21 2003 | DEXCOM, INC | Porous membranes for use with implantable devices |
7198606, | Apr 19 2002 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for a multi-use body fluid sampling device with analyte sensing |
7225535, | Oct 08 1998 | Abbott Diabetes Care Inc | Method of manufacturing electrochemical sensors |
7226978, | May 22 2002 | DexCom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
7267665, | Jun 03 1999 | MEDTRONIC MINIMED, INC | Closed loop system for controlling insulin infusion |
7276029, | Aug 01 2003 | DEXCOM, INC | System and methods for processing analyte sensor data |
7299082, | Oct 31 2003 | Abbott Diabetes Care Inc | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
7310544, | Jul 13 2004 | DexCom, Inc. | Methods and systems for inserting a transcutaneous analyte sensor |
7335294, | Feb 06 1997 | Abbott Diabetes Care Inc | Integrated lancing and measurement device and analyte measuring methods |
7354420, | Jun 03 1999 | Medtronic MiniMed, Inc. | Closed loop system for controlling insulin infusion |
7364592, | Feb 12 2004 | DEXCOM, INC | Biointerface membrane with macro-and micro-architecture |
7366556, | Oct 04 2006 | DEXCOM, INC | Dual electrode system for a continuous analyte sensor |
7379765, | Jul 25 2003 | DEXCOM, INC | Oxygen enhancing membrane systems for implantable devices |
7401111, | Dec 04 1997 | Roche Diabetes Care, Inc | Instrument setup utility program |
7402153, | Jun 03 1999 | Medtronic MiniMed, Inc. | Closed-loop method for controlling insulin infusion |
7424318, | Oct 04 2006 | DEXCOM, INC | Dual electrode system for a continuous analyte sensor |
7460898, | Oct 04 2006 | DEXCOM, INC | Dual electrode system for a continuous analyte sensor |
7467003, | Dec 05 2003 | DEXCOM, INC | Dual electrode system for a continuous analyte sensor |
7471972, | Jul 27 2001 | DexCom, Inc. | Sensor head for use with implantable devices |
7494465, | Jul 13 2004 | DEXCOM, INC | Transcutaneous analyte sensor |
7497827, | Jul 13 2004 | DexCom, Inc. | Transcutaneous analyte sensor |
7519408, | Nov 19 2003 | DEXCOM, INC | Integrated receiver for continuous analyte sensor |
7547281, | Feb 01 2005 | MEDTRONICS MINIMED, INC | Algorithm sensor augmented bolus estimator for semi-closed loop infusion system |
7569030, | Sep 07 2001 | Medtronic MiniMed, Inc. | Safety limits for closed-loop infusion pump control |
7583990, | Aug 01 2003 | DexCom, Inc. | System and methods for processing analyte sensor data |
7591801, | Feb 26 2004 | DEXCOM, INC | Integrated delivery device for continuous glucose sensor |
7599726, | Aug 01 2003 | DexCom, Inc. | System and methods for processing analyte sensor data |
7613491, | Apr 14 2006 | DEXCOM, INC | Silicone based membranes for use in implantable glucose sensors |
7615007, | Oct 04 2006 | DEXCOM, INC | Analyte sensor |
7618369, | Oct 02 2006 | ABBOTT DIABETES CARE, INC | Method and system for dynamically updating calibration parameters for an analyte sensor |
7632228, | Jul 27 2001 | DexCom, Inc. | Membrane for use with implantable devices |
7637868, | Jan 12 2004 | DEXCOM, INC | Composite material for implantable device |
7640048, | Jul 13 2004 | DEXCOM, INC | Analyte sensor |
7651596, | Apr 08 2005 | DEXCOM, INC | Cellulosic-based interference domain for an analyte sensor |
7654956, | Jul 13 2004 | DexCom, Inc. | Transcutaneous analyte sensor |
7657297, | May 03 2004 | DEXCOM, INC | Implantable analyte sensor |
7711402, | Mar 04 1997 | DexCom, Inc. | Device and method for determining analyte levels |
7713574, | Jul 13 2004 | DexCom, Inc. | Transcutaneous analyte sensor |
7715893, | Dec 05 2003 | DEXCOM, INC | Calibration techniques for a continuous analyte sensor |
7826981, | Aug 01 2003 | DexCom, Inc. | System and methods for processing analyte sensor data |
7885698, | Feb 28 2006 | ABBOTT DIABETES CARE, INC | Method and system for providing continuous calibration of implantable analyte sensors |
7912655, | Aug 05 2005 | Ascensia Diabetes Care Holdings AG | Meter having multi-level user interface |
7912674, | Oct 31 2006 | Roche Diabetes Care, Inc | Method for processing a chronological sequence of measurements of a time dependent parameter |
7928850, | May 08 2007 | ABBOTT DIABETES CARE, INC | Analyte monitoring system and methods |
7976467, | Dec 29 2004 | Cilag GmbH International; Lifescan IP Holdings, LLC | Method of inputting data into analyte testing device |
8066639, | Jun 10 2003 | Abbott Diabetes Care Inc | Glucose measuring device for use in personal area network |
20020019022, | |||
20020042090, | |||
20020095076, | |||
20020103499, | |||
20020106709, | |||
20020128594, | |||
20020161288, | |||
20020169635, | |||
20030004403, | |||
20030023317, | |||
20030032874, | |||
20030042137, | |||
20030065308, | |||
20030100821, | |||
20030125612, | |||
20030130616, | |||
20030134347, | |||
20030168338, | |||
20030176933, | |||
20030187338, | |||
20030199790, | |||
20030208113, | |||
20030212317, | |||
20030212379, | |||
20030216630, | |||
20030217966, | |||
20040010207, | |||
20040011671, | |||
20040039298, | |||
20040040840, | |||
20040045879, | |||
20040064068, | |||
20040106858, | |||
20040122353, | |||
20040133164, | |||
20040138588, | |||
20040146909, | |||
20040152622, | |||
20040167801, | |||
20040171921, | |||
20040176672, | |||
20040186362, | |||
20040186365, | |||
20040193025, | |||
20040193090, | |||
20040197846, | |||
20040199059, | |||
20040204687, | |||
20040225338, | |||
20040236200, | |||
20040254433, | |||
20040267300, | |||
20050004439, | |||
20050004494, | |||
20050010269, | |||
20050027177, | |||
20050031689, | |||
20050038332, | |||
20050043598, | |||
20050090607, | |||
20050096511, | |||
20050096512, | |||
20050112169, | |||
20050113653, | |||
20050114068, | |||
20050121322, | |||
20050131346, | |||
20050143635, | |||
20050176136, | |||
20050177398, | |||
20050182306, | |||
20050187720, | |||
20050192494, | |||
20050192557, | |||
20050195930, | |||
20050199494, | |||
20050203360, | |||
20050239154, | |||
20050241957, | |||
20050245795, | |||
20050245799, | |||
20050245839, | |||
20050245904, | |||
20050287620, | |||
20060001538, | |||
20060004270, | |||
20060015020, | |||
20060015024, | |||
20060016700, | |||
20060019327, | |||
20060020186, | |||
20060020187, | |||
20060020188, | |||
20060020189, | |||
20060020190, | |||
20060020191, | |||
20060020192, | |||
20060029177, | |||
20060031094, | |||
20060036139, | |||
20060036140, | |||
20060036141, | |||
20060036142, | |||
20060036143, | |||
20060036144, | |||
20060036145, | |||
20060155180, | |||
20060166629, | |||
20060173260, | |||
20060173406, | |||
20060173444, | |||
20060183985, | |||
20060189863, | |||
20060222566, | |||
20060224109, | |||
20060229512, | |||
20060247508, | |||
20060272652, | |||
20070016381, | |||
20070027381, | |||
20070032706, | |||
20070033074, | |||
20070038053, | |||
20070060814, | |||
20070066873, | |||
20070071681, | |||
20070073129, | |||
20070078314, | |||
20070078320, | |||
20070078321, | |||
20070078322, | |||
20070078323, | |||
20070106135, | |||
20070124002, | |||
20070149875, | |||
20070163880, | |||
20070168224, | |||
20070173706, | |||
20070173761, | |||
20070179349, | |||
20070179352, | |||
20070191701, | |||
20070203407, | |||
20070203966, | |||
20070232880, | |||
20070235331, | |||
20070249922, | |||
20080009692, | |||
20080017522, | |||
20080021666, | |||
20080029391, | |||
20080033254, | |||
20080039702, | |||
20080045824, | |||
20080058625, | |||
20080064937, | |||
20080071156, | |||
20080071157, | |||
20080071158, | |||
20080071580, | |||
20080081977, | |||
20080083617, | |||
20080086042, | |||
20080086044, | |||
20080086273, | |||
20080097289, | |||
20080108942, | |||
20080154513, | |||
20080167543, | |||
20080172205, | |||
20080183060, | |||
20080183061, | |||
20080183399, | |||
20080188731, | |||
20080188796, | |||
20080189051, | |||
20080194935, | |||
20080194936, | |||
20080194937, | |||
20080194938, | |||
20080195232, | |||
20080195967, | |||
20080197024, | |||
20080200788, | |||
20080200789, | |||
20080200791, | |||
20080208025, | |||
20080208113, | |||
20080214915, | |||
20080214918, | |||
20080228051, | |||
20080228054, | |||
20080234992, | |||
20080242961, | |||
20080255434, | |||
20080255437, | |||
20080255438, | |||
20080255808, | |||
20080256048, | |||
20080262469, | |||
20080275313, | |||
20080278331, | |||
20080287755, | |||
20080287761, | |||
20080287762, | |||
20080287763, | |||
20080287764, | |||
20080287765, | |||
20080287766, | |||
20080288180, | |||
20080288204, | |||
20080296155, | |||
20080300572, | |||
20080306368, | |||
20080306434, | |||
20080306435, | |||
20080306444, | |||
20080312841, | |||
20080312842, | |||
20080312844, | |||
20080312845, | |||
20090005665, | |||
20090006034, | |||
20090012379, | |||
20090018424, | |||
20090018425, | |||
20090030294, | |||
20090033482, | |||
20090036747, | |||
20090036758, | |||
20090036760, | |||
20090036763, | |||
20090043181, | |||
20090043182, | |||
20090043525, | |||
20090043541, | |||
20090043542, | |||
20090045055, | |||
20090054750, | |||
20090055149, | |||
20090062633, | |||
20090062635, | |||
20090062767, | |||
20090063402, | |||
20090076356, | |||
20090076360, | |||
20090076361, | |||
20090099436, | |||
20090105570, | |||
20090105636, | |||
20090112154, | |||
20090124877, | |||
20090124878, | |||
20090124879, | |||
20090124964, | |||
20090131768, | |||
20090131769, | |||
20090131776, | |||
20090131777, | |||
20090137886, | |||
20090137887, | |||
20090143659, | |||
20090143660, | |||
20090156919, | |||
20090156924, | |||
20090157430, | |||
20090163790, | |||
20090163791, | |||
20090164190, | |||
20090164239, | |||
20090164251, | |||
20090178459, | |||
20090182217, | |||
20090192366, | |||
20090192380, | |||
20090192722, | |||
20090192724, | |||
20090192745, | |||
20090192751, | |||
20090198118, | |||
20090203981, | |||
20090204341, | |||
20090210249, | |||
20090216103, | |||
20090240120, | |||
20090240128, | |||
20090240193, | |||
20090242399, | |||
20090242425, | |||
20090247855, | |||
20090247856, | |||
20090247857, | |||
20090287073, | |||
20090287074, | |||
20090299155, | |||
20090299156, | |||
20090299162, | |||
20090299276, | |||
20100010324, | |||
20100010331, | |||
20100010332, | |||
20100016687, | |||
20100016698, | |||
20100022855, | |||
20100030038, | |||
20100030053, | |||
20100030484, | |||
20100030485, | |||
20100036215, | |||
20100036216, | |||
20100036222, | |||
20100036223, | |||
20100036225, | |||
20100041971, | |||
20100045465, | |||
20100049024, | |||
20100057040, | |||
20100057041, | |||
20100057042, | |||
20100057044, | |||
20100057057, | |||
20100063373, | |||
20100076283, | |||
20100081906, | |||
20100081908, | |||
20100081910, | |||
20100087724, | |||
20100096259, | |||
20100099970, | |||
20100099971, | |||
20100119693, | |||
20100121169, | |||
20100152548, | |||
20100160757, | |||
20100191085, | |||
20100191087, | |||
20100191472, | |||
20100204557, | |||
20100234710, | |||
20100259543, | |||
20100274515, | |||
20100331651, | |||
20110004085, | |||
20110021889, | |||
20110077469, | |||
20110123971, | |||
20110137571, | |||
20110184752, | |||
20110208027, | |||
20110263959, | |||
20110264378, | |||
CA2468577, | |||
CA2617965, | |||
CA2626349, | |||
CA2678336, | |||
CA2728831, | |||
DE4401400, | |||
EP98592, | |||
EP127958, | |||
EP286118, | |||
EP320109, | |||
EP353328, | |||
EP390390, | |||
EP396788, | |||
EP1048264, | |||
EP1725163, | |||
EP2031534, | |||
WO49940, | |||
WO59370, | |||
WO78992, | |||
WO152935, | |||
WO154753, | |||
WO2058537, | |||
WO216905, | |||
WO3057027, | |||
WO3076893, | |||
WO3082091, | |||
WO3085372, | |||
WO2004061420, | |||
WO2005041766, | |||
WO2005057175, | |||
WO2005065538, | |||
WO2005089103, | |||
WO2006020212, | |||
WO2006024671, | |||
WO2006072035, | |||
WO2006079114, | |||
WO2006118947, | |||
WO2007016399, | |||
WO2007019289, | |||
WO2007027788, | |||
WO2007041069, | |||
WO2007041070, | |||
WO2007041248, | |||
WO2007053832, | |||
WO2007056638, | |||
WO2007101223, | |||
WO2007120363, | |||
WO2007126444, | |||
WO2007143225, | |||
WO2008021913, | |||
WO2008042760, | |||
WO2008048452, | |||
WO2008052374, | |||
WO2008062099, | |||
WO2008128210, | |||
WO2008130896, | |||
WO2008130897, | |||
WO2008130898, | |||
WO2008143943, | |||
WO2008144445, | |||
WO2009018058, | |||
WO2009086216, | |||
WO2009096992, | |||
WO2009097594, | |||
WO2010062898, | |||
WO2011000528, | |||
WO2011104616, | |||
WO9625089, | |||
WO9635370, | |||
WO9835053, | |||
WO9927849, | |||
WO9928736, | |||
WO9956613, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Apr 28 2010 | Abbott Diabetes Care Inc. | (assignment on the face of the patent) | / | |||
May 06 2010 | HARPER, WESLEY SCOTT | Abbott Diabetes Care Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 024522 | /0234 |
Date | Maintenance Fee Events |
May 12 2015 | ASPN: Payor Number Assigned. |
Dec 28 2016 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Dec 18 2020 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Date | Maintenance Schedule |
Jul 09 2016 | 4 years fee payment window open |
Jan 09 2017 | 6 months grace period start (w surcharge) |
Jul 09 2017 | patent expiry (for year 4) |
Jul 09 2019 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jul 09 2020 | 8 years fee payment window open |
Jan 09 2021 | 6 months grace period start (w surcharge) |
Jul 09 2021 | patent expiry (for year 8) |
Jul 09 2023 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jul 09 2024 | 12 years fee payment window open |
Jan 09 2025 | 6 months grace period start (w surcharge) |
Jul 09 2025 | patent expiry (for year 12) |
Jul 09 2027 | 2 years to revive unintentionally abandoned end. (for year 12) |